The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4685
Abstract: Prognostic indicators based on the initial prostate‐specific antigen (PSA) levels, nadir PSA, and time to PSA nadir were calculated to evaluate prognosis after primary androgen deprivation therapy (PADT), as these have been reported in very… read more here.
Keywords: prostate specific; prostate; specific antigen; primary androgen ... See more keywords
Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5651
Abstract: Androgen deprivation therapy (ADT), used increasingly in the treatment of prostate cancer (PCa), negatively influences glycemic control in diabetes and is associated with an increased risk of diabetes complications where hospitalization commonly ensues. Metformin could… read more here.
Keywords: prostate cancer; deprivation therapy; androgen deprivation; resources utilization ... See more keywords
Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31171
Abstract: Strategies to improve bone health care in men receiving androgen deprivation therapy (ADT) are not consistently implemented. The authors conducted a phase 2 randomized controlled trial of 2 education‐based models‐of‐care interventions to determine their feasibility… read more here.
Keywords: receiving androgen; bone health; bone; deprivation therapy ... See more keywords
Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings
Sign Up to like & getrecommendations! Published in 2020 at "Cancer"
DOI: 10.1002/cncr.33397
Abstract: Increases in fatigue, depressive symptomatology, and cognitive impairment are common after the initiation of androgen deprivation therapy (ADT) for prostate cancer. To date, no studies have examined the potential role of inflammation in the development… read more here.
Keywords: symptomatology; prostate cancer; deprivation therapy; cancer ... See more keywords
Assessing salivary matrix metalloproteinase‐8 in prostate cancer patients undergoing androgen deprivation therapy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dental Research"
DOI: 10.1002/cre2.624
Abstract: Matrix metalloproteinase‐8 (MMP‐8) is considered as one of the most promising diagnostic markers for periodontal disease. Androgen deprivation therapy (ADT) has been correlated with impaired collagen synthesis and an increase in periodontal tissue susceptibility to… read more here.
Keywords: androgen deprivation; matrix metalloproteinase; deprivation therapy;
The impact of hegemonic masculine ideals on self‐esteem in prostate cancer patients undergoing androgen deprivation therapy (ADT) compared to ADT‐naïve patients
Sign Up to like & getrecommendations! Published in 2022 at "Psycho-Oncology"
DOI: 10.1002/pon.6001
Abstract: Androgen deprivation therapy (ADT) for Prostate Cancer (PCa) is associated with side effects that could lead to negative body image and low masculine self‐esteem of survivors. We compared a group of PCa survivors following ADT… read more here.
Keywords: therapy adt; self esteem; prostate cancer; masculine ... See more keywords
Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-019-00854-y
Abstract: Background The survival rate of prostate cancer is relatively higher than other cancers, therefore, the health-related quality of life (HRQoL) becomes a critical issue for the patients. There are limited quality of life data evaluating the… read more here.
Keywords: androgen deprivation; deprivation therapy; quality life;
Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort study
Sign Up to like & getrecommendations! Published in 2022 at "International Urology and Nephrology"
DOI: 10.1007/s11255-022-03151-2
Abstract: Androgen deprivation therapy (ADT) use in prostate cancer (PCa) has seen a rising trend. We are looking into the relationship between ADT and development of metabolic diseases in Chinese patients. This is a prospective multi-centre… read more here.
Keywords: deprivation therapy; androgen deprivation; prospective multi; metabolic diseases ... See more keywords
Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Current Oncology Reports"
DOI: 10.1007/s11912-020-0884-1
Abstract: Purpose of Review Androgen deprivation therapy (ADT) is widely used in prostate cancer. Interest in assessing how ADT impacts cognition is growing. Recent Findings Studies in animals and humans suggest that androgens may affect cognitive… read more here.
Keywords: cognitive function; androgen deprivation; deprivation therapy; prostate cancer ... See more keywords
Outcomes of patients older than 75 years with non-metastatic prostate cancer
Sign Up to like & getrecommendations! Published in 2017 at "Asian Journal of Urology"
DOI: 10.1016/j.ajur.2016.12.001
Abstract: Objective Prostate cancer in elderly patients was formerly treated with androgen deprivation therapy. Since the latter of the 1990s new technologies were introduced into treatments, then strategies have varied. We aimed to observe the outcomes… read more here.
Keywords: cancer; androgen deprivation; deprivation therapy; prostate cancer ... See more keywords
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "Cell reports"
DOI: 10.1016/j.celrep.2021.110109
Abstract: SUMMARY This study addresses the roles of nuclear receptor corepressor 2 (NCOR2) in prostate cancer (PC) progression in response to androgen deprivation therapy (ADT). Reduced NCOR2 expression significantly associates with shorter disease-free survival in patients… read more here.
Keywords: deprivation therapy; expression; androgen deprivation; reduced ncor2 ... See more keywords